video corpo

Analysis software BaseSpace Cohort
clinicalfor geneticslaboratory

analysis software
analysis software
analysis software
analysis software
analysis software
analysis software
analysis software
Add to favorites
Compare this product


Application domain
clinical, for genetics, laboratory, for pharmacies
analysis, visualization


BaseSpace Cohort Analyzer allows you to integrate and analyze subject and genomic data together using innovative visualization and analysis tools. BaseSpace Cohort Analyzer enables you to aggregate and analyze subject and genomic data with access to over 100 bioinformatics workflows. Academic centers and research hospitals, pharmaceutical and biotech companies, and population sequencing centers can accelerate biomarker and drug discovery, track longitudinal and outcome data, and compare subjects and cohorts for clinical trials.1 With BaseSpace Cohort Analyzer, researchers can: Integrate and analyze proprietary subject data with curated public content to enhance results interpretation Perform in silico trials to assess the value of biomarkers as companion diagnostics Assess drug targets with integrated genomic data from cell lines Access a manually curated collection of over 85,000 interpreted biomarkers for disease association, molecular classification, prognostic, predictive, drug target, and therapeutics information for research Identify candidate predictive biomarkers by retrospective analysis of clinical trials Define enrollment criteria to enrich clinical trials for subjects with optional response to therapy Support precision medicine and population sequencing efforts by giving researchers and collaborators access to content and analytics



No catalogs are available for this product.

See all of Illumina, Inc.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.